Crescendo Biologics presents preclinical data on lead clinical candidate CB307 and unveils its first ‘2 in 1’ immune cell engager CB699 at AACR 2024
April 10, 2024 07:00 ET
|
Crescendo Biologics
Crescendo Biologics presents preclinical data on lead clinical candidate CB307 and unveils its first ‘2 in 1’ immune cell engager CB699 at AACR 2024 Preclinical data demonstrate strong rationale for...
Lactoferrin Market to reach USD 505 Million by 2030 growing Steadily at a CAGR of 8.5%: Straits Research
May 26, 2022 11:30 ET
|
Straits Research
New York, United States, May 26, 2022 (GLOBE NEWSWIRE) -- Rising Demand for Lactoferrin in Sports and Infant Nutrition to Drive the Global Lactoferrin MarketMany athletes take iron supplements to...
LifeBank Chain Announces Upcoming Gene and Cell Collaboration Platform With Disrupt Blockchain Technologies
December 31, 2021 15:00 ET
|
LifeBank Chain
JERUSALEM, Dec. 31, 2021 (GLOBE NEWSWIRE) -- GENE & CELL MEDICINE LTD located in Israel and Singapore started a new project : LifeBank Chain (LBC). The project LBC plans to build a genetic and...